Reminder: Invitation to Roche ’s Full Year Results 2022 Presentation

  Roche will publish its Full Year Results for 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 2 February 2023. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before)Release will be e-mailed and posted on the Roche IR website>click herePresentation slides will be posted on the Roche IR website>click here The webinar will start with presentations by senior management,followed by a Q&A session.Presenters:Severin Schwan, CEO Roche GroupThomas Schinecker, CEO Roche Pharmaceuticals ad interimMatt Sause, CEO Roche DiagnosticsAlan Hippe, Chief Financial and IT Officer We would like to invite all interested parties to participate in the webinar and to pre-register for the eventhere* Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail]. A replay of the webcast will be available via>ir.roche.com*privacy notice Best regards,  Bruno EschliHead of Investor Relations   Roche Investor Relations Dr. Bruno EschliPhone: [phone]e-mail:[e-mail] Dr. SabineBorngr äberPhone: [phone]e-mail:[e-mail] Dr. BirgitMasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]  Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail] 

Source: Roche Investor Update - January 26, 2023 Category: Pharmaceuticals Source Type: news